Showing 42,981 - 43,000 results of 49,780 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.13s Refine Results
  1. 42981

    Meta-analysis of 3 manipulations of the insulin/Tor signaling identifies rover-biased genes. by Clement F. Kent (260706)

    Published 2009
    “…<p>Three published studies decreased insulin/Tor effects via (A) ablation of <i>dilp3</i> expressing cells <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000609#pgen.1000609-Buch1" target="_blank">[28]</a>, (B) overexpression of constitutively active <i>foxo </i><a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000609#pgen.1000609-Gershman1" target="_blank">[29]</a>, or (C) rapamycin <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000609#pgen.1000609-Guertin1" target="_blank">[30]</a>. …”
  2. 42982

    The expression profiles of the selected IFNα-stimulated genes are negatively influenced by the intracellular factor IRF2. by Katharina Robichon (8445099)

    Published 2020
    “…(<b>D</b>) Upregulation of gene expression by decreased <i>IRF2</i> expression. Huh7.5 cells were incubated with 50 nM siRNA directed against <i>IRF2</i> (orange) or non-targeting control (blue) for 24 hours, and then treated with 500 U/ml IFNα. …”
  3. 42983

    Effect of on Bepridil on APP processing. by Kamran Honarnejad (485648)

    Published 2013
    “…Sulindac sulfide (50 µM) was used as a γ-secretase modulator control. …”
  4. 42984

    Human heart mtDNA topology changes in early childhood and in mitochondrial disorders involving mutations in Twinkle and PolG. by Jaakko L. O. Pohjoismäki (249430)

    Published 2010
    “…<p>The basis of the assignment of the different molecular forms is presented in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010426#pone.0010426-Pohjoismki1" target="_blank">[5]</a>. …”
  5. 42985

    Table_2_Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients.docx by Supriya Khanra (5245634)

    Published 2022
    “…<p>The central theme of this enterprise is to find common features, if any, displayed by genetically different antimony (Sb)-resistant viscerotropic Leishmania parasites to impart Sb resistance. In a limited number of clinical isolates (n = 3), we studied the breadth of variation in the following dimensions: (a) intracellular thiol content, (b) cell surface expression of glycan having N-acetyl-D-galactosaminyl residue as the terminal sugar, and (c) gene expression of thiol-synthesizing enzymes (CBS, MST, gamma-GCS, ODC, and TR), antimony-reducing enzymes (TDR and ACR2), and antimonial transporter genes (AQP1, MRPA, and PRP1). …”
  6. 42986

    Identification of Glycoprotein Markers for Pancreatic Cancer CD24<sup>+</sup>CD44<sup>+</sup> Stem-like Cells Using Nano-LC–MS/MS and Tissue Microarray by Jianhui Zhu (678784)

    Published 2012
    “…Herein, the malignant phenotype of pancreatic cancer stem-like CD24<sup>+</sup>CD44<sup>+</sup> cells was isolated from a human pancreatic carcinoma cell line (PANC-1) and demonstrated 4-fold increased invasion ability compared to CD24<sup>–</sup>CD44<sup>+</sup> cells. …”
  7. 42987

    Table_1_Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients.xlsx by Supriya Khanra (5245634)

    Published 2022
    “…<p>The central theme of this enterprise is to find common features, if any, displayed by genetically different antimony (Sb)-resistant viscerotropic Leishmania parasites to impart Sb resistance. In a limited number of clinical isolates (n = 3), we studied the breadth of variation in the following dimensions: (a) intracellular thiol content, (b) cell surface expression of glycan having N-acetyl-D-galactosaminyl residue as the terminal sugar, and (c) gene expression of thiol-synthesizing enzymes (CBS, MST, gamma-GCS, ODC, and TR), antimony-reducing enzymes (TDR and ACR2), and antimonial transporter genes (AQP1, MRPA, and PRP1). …”
  8. 42988

    Structure–Activity Relationship of 3‑Methylcytidine-5′-α,β-methylenediphosphates as CD73 Inhibitors by Mirko Scortichini (4007366)

    Published 2022
    “…We now expand the structure–activity relationship of pyrimidine nucleotides as human CD73 inhibitors. 4-Chloro (MRS4598 <b>16</b>; <i>K</i><sub>i</sub> = 0.673 nM) and 4-iodo (MRS4620 <b>18</b>; <i>K</i><sub>i</sub> = 0.436 nM) substitution of the <i>N</i><sup>4</sup>-benzyloxy group decreased <i>K</i><sub>i</sub> by ∼20-fold. Primary alkylamine derivatives coupled through a <i>p</i>-amido group with a varying methylene chain length (<b>24</b> and <b>25</b>) were functionalized congeners, for subsequent conjugation to carrier or reporter moieties. …”
  9. 42989

    Identification of Glycoprotein Markers for Pancreatic Cancer CD24<sup>+</sup>CD44<sup>+</sup> Stem-like Cells Using Nano-LC–MS/MS and Tissue Microarray by Jianhui Zhu (678784)

    Published 2012
    “…Herein, the malignant phenotype of pancreatic cancer stem-like CD24<sup>+</sup>CD44<sup>+</sup> cells was isolated from a human pancreatic carcinoma cell line (PANC-1) and demonstrated 4-fold increased invasion ability compared to CD24<sup>–</sup>CD44<sup>+</sup> cells. …”
  10. 42990

    Presentation_2_Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients.pptx by Supriya Khanra (5245634)

    Published 2022
    “…<p>The central theme of this enterprise is to find common features, if any, displayed by genetically different antimony (Sb)-resistant viscerotropic Leishmania parasites to impart Sb resistance. In a limited number of clinical isolates (n = 3), we studied the breadth of variation in the following dimensions: (a) intracellular thiol content, (b) cell surface expression of glycan having N-acetyl-D-galactosaminyl residue as the terminal sugar, and (c) gene expression of thiol-synthesizing enzymes (CBS, MST, gamma-GCS, ODC, and TR), antimony-reducing enzymes (TDR and ACR2), and antimonial transporter genes (AQP1, MRPA, and PRP1). …”
  11. 42991

    GD3 Synthase Overexpression Sensitizes Hepatocarcinoma Cells to Hypoxia and Reduces Tumor Growth by Suppressing the cSrc/NF-κB Survival Pathway by Josep M. Lluis (256726)

    Published 2009
    “…<div><h3>Background</h3><p>Hypoxia-mediated HIF-1α stabilization and NF-κB activation play a key role in carcinogenesis by fostering cancer cell survival, angiogenesis and tumor invasion. …”
  12. 42992

    Presentation_3_Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients.pptx by Supriya Khanra (5245634)

    Published 2022
    “…<p>The central theme of this enterprise is to find common features, if any, displayed by genetically different antimony (Sb)-resistant viscerotropic Leishmania parasites to impart Sb resistance. In a limited number of clinical isolates (n = 3), we studied the breadth of variation in the following dimensions: (a) intracellular thiol content, (b) cell surface expression of glycan having N-acetyl-D-galactosaminyl residue as the terminal sugar, and (c) gene expression of thiol-synthesizing enzymes (CBS, MST, gamma-GCS, ODC, and TR), antimony-reducing enzymes (TDR and ACR2), and antimonial transporter genes (AQP1, MRPA, and PRP1). …”
  13. 42993

    Presentation_1_Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients.pptx by Supriya Khanra (5245634)

    Published 2022
    “…<p>The central theme of this enterprise is to find common features, if any, displayed by genetically different antimony (Sb)-resistant viscerotropic Leishmania parasites to impart Sb resistance. In a limited number of clinical isolates (n = 3), we studied the breadth of variation in the following dimensions: (a) intracellular thiol content, (b) cell surface expression of glycan having N-acetyl-D-galactosaminyl residue as the terminal sugar, and (c) gene expression of thiol-synthesizing enzymes (CBS, MST, gamma-GCS, ODC, and TR), antimony-reducing enzymes (TDR and ACR2), and antimonial transporter genes (AQP1, MRPA, and PRP1). …”
  14. 42994

    Structure–Activity Relationship of 3‑Methylcytidine-5′-α,β-methylenediphosphates as CD73 Inhibitors by Mirko Scortichini (4007366)

    Published 2022
    “…We now expand the structure–activity relationship of pyrimidine nucleotides as human CD73 inhibitors. 4-Chloro (MRS4598 <b>16</b>; <i>K</i><sub>i</sub> = 0.673 nM) and 4-iodo (MRS4620 <b>18</b>; <i>K</i><sub>i</sub> = 0.436 nM) substitution of the <i>N</i><sup>4</sup>-benzyloxy group decreased <i>K</i><sub>i</sub> by ∼20-fold. Primary alkylamine derivatives coupled through a <i>p</i>-amido group with a varying methylene chain length (<b>24</b> and <b>25</b>) were functionalized congeners, for subsequent conjugation to carrier or reporter moieties. …”
  15. 42995

    Competitive bio-panning assay shows specific binding of T7-ATERF-1 clone to the three strains of <i>Pseudomonas</i>. by Cristina Rioja (277145)

    Published 2013
    “…<p>(<b>A</b>) Competition between T7-ATERF-1 phage (which expresses ATERF-1 polypeptide) and T7-C1 (competing phage randomly selected). …”
  16. 42996

    Structure–Activity Relationship of 3‑Methylcytidine-5′-α,β-methylenediphosphates as CD73 Inhibitors by Mirko Scortichini (4007366)

    Published 2022
    “…We now expand the structure–activity relationship of pyrimidine nucleotides as human CD73 inhibitors. 4-Chloro (MRS4598 <b>16</b>; <i>K</i><sub>i</sub> = 0.673 nM) and 4-iodo (MRS4620 <b>18</b>; <i>K</i><sub>i</sub> = 0.436 nM) substitution of the <i>N</i><sup>4</sup>-benzyloxy group decreased <i>K</i><sub>i</sub> by ∼20-fold. Primary alkylamine derivatives coupled through a <i>p</i>-amido group with a varying methylene chain length (<b>24</b> and <b>25</b>) were functionalized congeners, for subsequent conjugation to carrier or reporter moieties. …”
  17. 42997

    Data Sheet 1_Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning.zip by Shuxian Pan (8868356)

    Published 2025
    “…However, Immunotherapy-related adverse reactions are still a major challenge faced by tumor immunotherapy, so it is urgent to establish new methods to effectively predict immunotherapy-related adverse reactions.…”
  18. 42998

    Text S1 - Down-Regulating Sphingolipid Synthesis Increases Yeast Lifespan by Xinhe Huang (185390)

    Published 2012
    “…Figure S2: Myriocin treatment decreases cell size. DBY746 cells were grown with and without myriocin (Myr) as in a CLS assay using SDC medium (pH 4.5, 3X iron). …”
  19. 42999
  20. 43000